Cardiac Marker Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Summary
GlobalData's Medical Devices sector report, “Cardiac Marker Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Cardiac Marker Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
A cardiac marker test is a biomarker test used to diagnosis cardiac diseases.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Cardiac Marker Tests under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Cardiac Marker Tests and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Cardiac Marker Tests under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
Introduction
Cardiac Marker Tests Overview
Products under Development
Cardiac Marker Tests - Pipeline Products by Stage of Development
Table Cardiac Marker Tests - Pipeline Products by Stage of Development
Table Cardiac Marker Tests - Pipeline Products by Stage of Development
Cardiac Marker Tests - Pipeline Products by Segment
Table Cardiac Marker Tests - Pipeline Products by Segment
Table Cardiac Marker Tests - Pipeline Products by Segment
Cardiac Marker Tests - Pipeline Products by Territory
Table Cardiac Marker Tests - Pipeline Products by Territory
Table Cardiac Marker Tests - Pipeline Products by Territory
Cardiac Marker Tests - Pipeline Products by Regulatory Path
Table Cardiac Marker Tests - Pipeline Products by Regulatory Path
Table Cardiac Marker Tests - Pipeline Products by Regulatory Path
Cardiac Marker Tests - Pipeline Products by Estimated Approval Date
Table Cardiac Marker Tests - Pipeline Products by Estimated Approval Date
Table Cardiac Marker Tests - Pipeline Products by Estimated Approval Date
Table ARCHITECT c8000 System - High Sensitive Troponin-I Assay - Australian New Zealand Acute Chest Pain (ANZACP) Registry: A Registry of the Investigation, Management and Outcomes of Patients Presenting to Two Australasian Hospitals with Chest Pain of Possible Cardiac Origin
Abbott Point of Care Inc Company Overview
Abbott Point of Care Inc Pipeline Products & Ongoing Clinical Trials Overview
Table Abbott Point of Care Inc Pipeline Products & Ongoing Clinical Trials Overview
Table i-STAT TnI-Nx - Product Status
Table i-STAT TnI-Nx - Product Description
Abionic SA Company Overview
Abionic SA Pipeline Products & Ongoing Clinical Trials Overview
Table Abionic SA Pipeline Products & Ongoing Clinical Trials Overview
Table Point of Care Diagnostic Test - Acute Myocardial Infarction - Product Status
Table Point of Care Diagnostic Test - Acute Myocardial Infarction - Product Description
Table Point of Care Diagnostic Test - Cardiac Troponin I (cTnI) - Product Status
Table Point of Care Diagnostic Test - Cardiac Troponin I (cTnI) - Product Description
Table Point of Care Diagnostic Test - High Sensitive C-reactive Protein (hsCRP) - Product Status
Table Point of Care Diagnostic Test - High Sensitive C-reactive Protein (hsCRP) - Product Description
Table Point of Care Diagnostic Test - Pro B-type Natriuretic Peptide (ProBNP) - Product Status
Table Point of Care Diagnostic Test - Pro B-type Natriuretic Peptide (ProBNP) - Product Description
Flinders University Pipeline Products & Ongoing Clinical Trials Overview
Table Flinders University Pipeline Products & Ongoing Clinical Trials Overview
Table Cardiac Troponin Blood Test - Product Status
Table Cardiac Troponin Blood Test - Product Description
Table Flinders University - Ongoing Clinical Trials Overview
Table Cardiac Troponin Blood Test - Rapid Assessment of Possible ACS In the emergency Department with High Sensitivity Troponin T (RAPID-TnT): Improving Decision-Making in the Face of Uncertainty: A Randomized trial of 0/1 hour High-Sensitivity Troponin in the investigation of Suspected ACS
French National Institute of Health and Medical Research Company Overview
French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview
Table French National Institute of Health and Medical Research Pipeline Products & Ongoing Clinical Trials Overview
Table Biomarker Based Assay - Atherosclerosis - Product Status
Table Biomarker Based Assay - Atherosclerosis - Product Description
Table Biomarker Based Assay - Cardiovascular Disease - Product Status
Table Biomarker Based Assay - Cardiovascular Disease - Product Description
G Medical Health and Wellness Company Overview
G Medical Health and Wellness Pipeline Products & Ongoing Clinical Trials Overview
Table G Medical Health and Wellness Pipeline Products & Ongoing Clinical Trials Overview
Table SomaSignal Test - Primary Cardiovascular Risk - Evaluating the Impact of SomaSignal Tests on Medical Management and Change in Risk in Patients at Higher Risk of Cardiovascular Disease: A Feasibility and an Adaptive Implementation Study (SomaSignal Study)
Soroka University Medical Center Company Overview
Soroka University Medical Center Pipeline Products & Ongoing Clinical Trials Overview
Table Soroka University Medical Center Pipeline Products & Ongoing Clinical Trials Overview
Table Saliva Based Cardiac Troponin Test - Product Status
Table Saliva Based Cardiac Troponin Test - Product Description
Dec 13, 2023: Pfizer Provides Full-Year 2024 Guidance
Dec 07, 2023: Johnson & Johnson to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Dec 05, 2023: Siemens Healthineers Appoints Vivek Kanade as New Head For Its Middle East and Africa Operations
Nov 30, 2023: Johnson & Johnson Names Eugene A. Woods, Chief Executive Officer of Advocate Health, to its Board of Directors
Nov 28, 2023: Thermo Fisher Scientific Prices Offering Of $2.5 Bln Of Senior Notes
Nov 27, 2023: Siemens Appoints Hakan Ozdemir as CEO of Smart Infrastructure in the Middle East
Nov 16, 2023: Censyn Secures NSF SBIR Grant and Arizona State Funding to Accelerate Commercialization of Innovative Neuro Health Medical Platform
Nov 15, 2023: StageZero Life Sciences, Ltd Announces Q3 2023 Financial Results and Operational Update
Nov 13, 2023: UCD Appoints new Vice-President for Research, Innovation and Impact
Oct 30, 2023: Upfront Diagnostics conducts final trial phase for POC stroke test
Oct 28, 2023: Pfizer Q2 Results: Drug Maker's Profit Declines 52% To Rs 149 Crore
Oct 24, 2023: Massachusetts General Hospital Researchers and Prevencio Announce AI-driven HART CVE Blood Test Accuracy for Patients with Coronary Chronic Total Occlusion
Oct 19, 2023: bioMérieux Makes Strategic Investment in Oxford Nanopore
Oct 18, 2023: Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range
Oct 17, 2023: Johnson & Johnson Reports Q3 2023 Results
Oct 05, 2023: Beckman Coulter Receives 510(k) Clearance for Access CEA Immunoassay
Oct 04, 2023: Kellina Yarrish Joins Hazleton student Engagement Team as Associate Director
Sep 28, 2023: Pfizer Appoints New Chief IR Officer
Sep 28, 2023: Office of Entrepreneurship and Commercialization Appoints Two New Directors
Sep 11, 2023: Aspira Women's Health Announces Dr. Jody Berry as New Chief Scientific Officer
Sep 01, 2023: Richard Roush to Step Down as Dean of the College of Agricultural Sciences
Aug 29, 2023: Co-Diagnostics Appoints Chief Regulatory Affairs Officer
Aug 28, 2023: Bio-Rad to Participate in Fireside Chat During Wells Fargo's 2023 Healthcare Conference
Aug 25, 2023: Proteome Sciences Announces Interim results for the six months ended 30 June 2023
Aug 24, 2023: LumiraDx Reports Second Quarter 2023 Results
Aug 21, 2023: Johnson & Johnson Announces Preliminary Results of Kenvue Inc. Exchange Offer
Aug 17, 2023: Mayo Clinic Reports Strong Finances for 2023 So Far with Q2 Revenue of $4.47 billion
Aug 16, 2023: LumiraDx to Announce Second Quarter Financial Results and Host Quarterly Conference Call on August 24
Aug 15, 2023: Tabitha Oman Named Penn State's New Vice President and General Counsel
Aug 14, 2023: Thermo Fisher Scientific to Trim Staff by More Than 200 at Florida Site
Aug 11, 2023: Kristin Peck, CEO of Zoetis, to join Mayo Clinic Board of Trustees
Aug 07, 2023: Penn State Names New Executive Director for Undergraduate Admissions
Jul 31, 2023: Roche Diagnostics Receives Additional 510(k) Clearance for Elecsys proBNP II
Jul 31, 2023: Roche Diagnostics Receives an Additional 510(k) Clearance for the Elecsys proBNP II STAT
Jul 24, 2023: Massachusetts General Hospital Researchers and Prevencio Announce the Power of Artificial Intelligence Hart Platform for Medical Diagnostic Test Development
Jul 18, 2023: Bob Darrah Named Senior Director of Development for College of Engineering
Jul 17, 2023: Quidel Cardiovascular Recalls Quidel Triage Cardiac Panels for Risk of False Negative Troponin Results that Could Cause Delayed Diagnosis or Missed Myocardial Infarction
Jul 17, 2023: AI-Supported Telemedicine Platform Aims to Improve the Health of Patients after Myocardial Infarction and Prevent Reinfarctions
Jul 05, 2023: Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 26, 2023
Jun 30, 2023: MedMira Reports Third Quarter Results FY2023
Jun 27, 2023: bioMErieux's Executive Committee evolves: Jennifer Zinn appointed Executive Vice President of Clinical Operations
Jun 12, 2023: Abbott Names Philip Boudreau CFO effective Sept. 1
Jun 06, 2023: Precision Neuroscience Begins First-In-Human Study of Its Neural Interface Technology
Jun 05, 2023: Biocartis Announces Resignation CFO
Jun 05, 2023: StageZero Life Sciences Announces Special and Annual General Meeting Conference Call
Jun 01, 2023: CAMH study confirms ongoing brain inflammation associated with long COVID
May 19, 2023: Health Canada grants license for Quidel TriageTrue high-sensitivity troponin I test to aid in the diagnosis of Myocardial Infarction
May 16, 2023: Abbott Laboratories receives additional 510(k) clearance for Alinity i STAT High Sensitivity Troponin-I
May 15, 2023: T2 Biosystems postpones reporting of first quarter 2023 financial results
May 12, 2023: Biocartis Group announces results of the annual shareholders meeting held on 12 May 2023
May 09, 2023: Grifols delivers strong first quarter financials with 23% revenue growth and an adjusted EBITDA margin above guidance of 21%
May 09, 2023: LumiraDx to announce first quarter financial results and host quarterly conference call on May 16
May 05, 2023: Co-Diagnostics announces first quarter 2023 earnings release date and webcast
Apr 28, 2023: Siemens to announce second quarter results FY 2023
Apr 18, 2023: Johnson & Johnson Reports Q1 2023 Results
Apr 11, 2023: Biocartis appoints Roger Moody as new CEO
Apr 11, 2023: J&J talc unit 2nd bankruptcy must be dismissed
Apr 06, 2023: MMT Ambulance Appoints Chris Ciatto as New CEO
Apr 04, 2023: Shineco subsidiary's `Cardiac 5-Minute Test' Passes Quality Inspection by China Regulator NMPA
Apr 04, 2023: MedMira Reports Second Quarter Results FY2023
Apr 04, 2023: Proteome Sciences Announces Final Results
Mar 31, 2023: StageZero Life Sciences Announces Q4 2022 and Year End Financial Results and Operational Update
Mar 30, 2023: StageZero to Issue Q4 2022 Financial Results on Friday March 31
Mar 29, 2023: StageZero to Issue Q4 2022 Financial Results and Hold Conference Call on Thursday March 30
Mar 14, 2023: LumiraDx to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Quarterly Conference Call on March 21
Mar 13, 2023: T2 Biosystems Announces Fourth Quarter and Full Year 2022 Financial Results
Mar 09, 2023: Co-diagnostics Announces Fourth Quarter and Full Year 2022 Earnings Release Date and Webcast
Mar 09, 2023: Penn State Smeal Tarriff Center adds two members to advisory board
Mar 08, 2023: bioMerieux Announces 2022 Financial Results for the year ending December 31, 2022
Mar 08, 2023: UCSF Health Appoints Two Prominent Healthcare Executives to Senior Leadership Positions
Mar 03, 2023: Grifols Announces Full Year 2022 Earnings
Feb 23, 2023: Biocartis announces 2022 results and 2023 outlook
Feb 22, 2023: Thomas Glanzmann new Grifols Executive Chairman, after Steven F. Mayer resignation
Feb 14, 2023: Siemens Limited announces Q1 FY 2023 results; 80% increase in PAT from continuing operations
Feb 10, 2023: Aistrosight: New joint project team between Theranexus, Inria, Claude Bernard university lyon 1 and hospices civils de lyon targeting rare neurological diseases
Feb 09, 2023: Pfizer Announces Appointment of Meenakshi Nevatia as the Managing Director
Feb 08, 2023: Siemens Announces Earnings Release and Financial Results for the First Quarter of Fiscal Year 2023
Feb 08, 2023: Siemens Announces Earnings Release Q1 FY 2023
Feb 01, 2023: Canon posts record revenues in medical business unit
Jan 31, 2023: DiagnaMed Holdings provides update for BRAIN AGE development and commercialization milestones for 2023
Jan 25, 2023: Hackensack Meridian JFK Johnson Rehabilitation Institute is researching a breakthrough wearable medical device to accelerate healing after a stroke
Jan 23, 2023: T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2022 Financial Results
Jan 20, 2023: Quest Diagnostics to Release Fourth Quarter and Full Year 2022 Financial Results on February 2, 2023
Jan 16, 2023: University of Waterloo : Using machine learning to predict brain tumour progression
Jan 10, 2023: Prevencio announces National Medicare pricing for company's three AI-powered HART cardiac blood tests
Jan 06, 2023: Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023
Dec 30, 2022: MedMira Reports First Quarter Results FY2023
Dec 20, 2022: European Investment Bank finances innovative diagnostics developer Numares Health with 20 million